This article was written by

Analyst’s Disclosure: I/we have a beneficial long position in the shares of EBKDY either through stock ownership, options, or other derivatives. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

While this article may sound like financial advice, please observe that the author is not a CFA or in any way licensed to give financial advice. It may be structured as such, but it is not financial advice. Investors are required and expected to do their own due diligence and research prior to any investment.

Short-term trading, options trading/investment, and futures trading are potentially extremely risky investment styles. They generally are not appropriate for someone with limited capital, limited investment experience, or a lack of understanding of the necessary risk tolerance involved.

I own the European/Scandinavian tickers (not the ADRs) of all European/Scandinavian companies listed in my articles. I own the Canadian tickers of all Canadian stocks I write about.

Please note that investing in European/Non-US stocks comes with withholding tax risks specific to the company’s domicile as well as your personal situation. Investors should always consult a tax professional as to the overall impact of dividend withholding taxes and ways to mitigate these.

Seeking Alpha’s Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.

Heightened geopolitical tensions in the Middle East are keeping global markets on edge, with investors closely monitoring the situation involving Iran as key deadlines draw near. The sharp rhetoric from the United States, coupled with Iran’s steady but firm positioning, has created a climate of deep uncertainty. With no clear direction on how negotiations will unfold, market participants are bracing for volatility.

Speaking with ET Now, James Knightley from ING noted, “It is a really difficult one to call. There is a huge amount of uncertainty, and markets will remain on tenterhooks until the deadline is hit.”

The ripple effects of this uncertainty are being felt in the inflation outlook as well, with central banks increasingly focusing on price stability amid rising energy costs. Supply disruptions linked to the conflict have pushed oil prices higher, reviving fears of inflationary pressures at a time when growth remains uneven. However, the current situation differs from the post-pandemic surge, particularly in terms of demand dynamics. James Knightley pointed out, “The Fed does not have the tools to deal with supply shocks—they cannot print oil,” highlighting the limitations of monetary policy in such scenarios. Importantly, weaker demand conditions could act as a counterbalance, with Knightley adding, “This supply shock is more demand-destructive, so we may not see broad and persistent inflation.”

Crude oil continues to be the most sensitive asset in this environment, reacting swiftly to every geopolitical development. While a potential easing of tensions could lead to a decline in prices, the trajectory remains uncertain. The extent of any correction will largely depend on the level of damage to supply infrastructure and how quickly normalcy can be restored. As James Knightley observed, “Oil could fall if tensions ease, but the extent will depend on the damage to infrastructure,” suggesting that prices may not revert to earlier levels anytime soon.

Given these uncertainties, investors are leaning towards a defensive stance, favouring safer assets amid the lack of clarity. The risk of sudden disruptions or unexpected escalations remains a key concern, even if a temporary agreement is reached. Reflecting the cautious mood, James Knightley added, “Safe haven is still the key right now, as the backdrop remains cautious.” Until there is greater visibility on both geopolitical and economic fronts, markets are likely to stay reactive, with risk aversion shaping investment decisions.

Melbourne, Australia — Melbourne has solidified its position as Australia’s leading hub for artificial intelligence innovation in 2026, home to about 188 AI companies and roughly 22% of the nation’s clustered AI firms — the largest concentration nationwide. With Victoria’s government-backed AI Mission Statement targeting up to $30 billion in gross state product contributions over the next decade, a new wave of emerging startups is driving breakthroughs in healthcare, legal tech, clinical documentation and beyond.

As global interest in responsible AI grows, Melbourne’s ecosystem benefits from strong university ties, a deep talent pool and proximity between research institutions and commercial ventures. While Sydney often dominates total funding, Melbourne excels in application-layer AI companies focused on real-world problems in medicine, compliance and productivity.

Here are 10 rising AI companies in Melbourne making waves in 2026, selected for their recent funding momentum, technological innovation and growth potential:

1. Heidi Health stands out as one of Melbourne’s fastest-growing AI healthtech stars. The company develops an AI-powered medical scribe platform that transcribes doctor-patient consultations and generates structured clinical notes, helping reduce administrative burdens and combat clinician burnout. Founded in 2021, Heidi has raised nearly $100 million, including a major Series B round valuing the company at around $465-711 million. It now processes millions of patient interactions weekly and adheres to strict standards like HIPAA, GDPR and Australian privacy principles. Investors including Point72, Blackbird and Headline back its vision of becoming an “AI care partner” for every clinician.
2. Harrison.ai continues to lead in medical imaging AI. The company, co-founded by brothers Dr. Aengus Tran and Dimitry Tran, builds deep learning tools like Annalise.ai to assist radiologists in detecting conditions such as cancer and neurological disorders. It has secured over $240 million in total funding, including a notable Series C raise, and operates in more than 1,000 healthcare facilities across 15 countries. Harrison.ai exemplifies Melbourne’s ability to produce globally scalable clinical AI with measurable impact on diagnostic accuracy and speed.
3. Affinda harnesses AI to transform document processing and data extraction for businesses. The Melbourne-based startup uses machine learning to automate invoice handling, contract analysis and other paperwork-heavy tasks, helping companies reduce manual errors and accelerate workflows. It has attracted attention for its practical enterprise applications and continues to expand its client base across Australia and internationally.
4. See-Mode Technologies specializes in AI for vascular and medical imaging analysis, particularly for stroke detection and management. The company has raised funding for its platform that provides real-time insights from ultrasound and other scans, supporting clinicians with faster, more accurate decisions. Its technology highlights Melbourne’s strength in specialized computer vision applications for healthcare.
5. Vervoe offers an AI-driven skills assessment platform that evaluates job candidates through realistic task simulations rather than traditional resumes. Founded in Melbourne, it uses AI grading to rank applicants based on actual job performance, helping employers make better hiring decisions. The company has gained traction in a competitive recruitment market and continues refining its role-specific assessment tools.
6. 6clicks has emerged as a trending AI startup focused on governance, risk and compliance (GRC) automation. Its platform leverages artificial intelligence to streamline regulatory compliance, policy management and audit processes for organizations. With rising search interest and reported growth of over 100% in some metrics, 6clicks addresses growing demand for trusted AI tools amid increasing regulatory scrutiny.
7. Isaacus represents an emerging legal AI player developing foundational models specifically for legal technology. Launched in 2025, the pre-seed funded startup (A$700,000) builds core AI capabilities that enable other companies to create specialized legal tools. Its focus on foundational research positions it as a behind-the-scenes enabler in Melbourne’s growing legal tech scene.
8. Lyrebird Health develops AI-powered medical documentation tools that transcribe consultations into structured notes, similar to but distinct from broader scribe platforms. The Melbourne startup targets efficiency gains for clinicians and has shown strong early traction in healthtech circles, benefiting from the city’s concentration of medical research institutions.
9. Everlab takes a preventative approach with its AI-driven personalized health assessments and care plans. The membership-based platform uses artificial intelligence for early disease detection and long-term wellness tracking. Founded in 2023, it appeals to consumers seeking proactive health management and has raised interest for its blend of diagnostics and AI personalization.
10. Restoke.ai and similar emerging players like Optain Health or Cor focus on niche applications such as retail optimization, ophthalmology imaging or specialized automation. Restoke.ai, for instance, applies AI to hospitality and inventory challenges, while others target computer vision in specific medical fields. These startups illustrate the breadth of Melbourne’s AI innovation beyond headline healthtech names.

Melbourne’s AI ecosystem benefits from supportive infrastructure, including events like the NORTH Link AI Summit and ongoing collaborations with institutions such as universities and innovation centers. Government initiatives emphasize responsible AI deployment, data governance and talent development, helping local startups navigate ethical considerations while scaling.

Funding trends show AI capturing a significant share of Australian venture capital, with Melbourne companies benefiting from local and international investors. However, challenges remain: competition for talent, the need for robust datasets and ensuring AI systems meet high compliance standards in regulated sectors like healthcare and finance.

Many of these rising companies emphasize practical outcomes — reducing doctor burnout, improving hiring accuracy or automating compliance — rather than hype. This focus on measurable ROI has helped attract capital even as global markets remain selective.

Industry observers note that Melbourne’s proximity to research hubs gives it an edge in translating academic work into commercial products, particularly in health AI and applied machine learning. Victoria’s AI Mission Statement aims to accelerate adoption across small and medium enterprises, creating further opportunities for these startups to partner with local businesses.

As 2026 progresses, expect more activity in generative AI agents, computer vision enhancements and industry-specific solutions. Some companies are already exploring international expansion, leveraging Australia’s strong data privacy reputation as a competitive advantage.

Travelers and tech professionals visiting Melbourne can engage with the scene through networking events, pitch nights and conferences focused on AI engineering and design. The city’s livable environment and strong tech community continue to draw talent from across Australia and abroad.

While larger players like Airwallex incorporate significant AI capabilities into fintech, the pure-play startups listed here represent the innovative edge pushing Melbourne forward. Their success could help the city capture more of the projected economic upside from AI in the coming years.

With continued government support and investor confidence, these 10 rising AI companies — and dozens more — position Melbourne as a serious contender in the global artificial intelligence landscape, blending technical excellence with solutions to everyday challenges in healthcare, business and beyond.